| 期刊論文| 1. | Degkwitz, R.、Luzenburger, O.(1965)。Das terminale extrapyramidale Insuffizienz-bzw. Defektsyndrom infolge chronischer Anwondung von Neuroleptika。Nervenarzt，36，173-175。   | | 2. | Saikia, J.K.、Jorgensen, A.(1983)。Steady-state serum concentrations after cis(Z)-flupentixol decanoate inviscoleo。Psychopharmacology，80，371-373。 | | 3. | Astrup, C.、Grimgard, A.、Hebnes, K.、Kruse-Jensen, A.、Lid, M.(1974)。A study of flupenthixol decanoate and pipothiazine undecylenate in schizophrenics。Acta Psychiatr Scand，50，481-491。 | | 4. | Gottfries, C. G.(1971)。Klinisk prOvning av flupenthixol decanoate som adepa-neuroleptikum。Nord PsykiatrTidsskr，25，296-303。 | | 5. | Chong, S.A.、Mythily, Lum, A.、Huak, C.Y.、Kane, J.(2002)。Tardive dyskinesia and impaired glucose tolerance。Hum Psychopharmacol，17，305-307。 | | 6. | Jeste, D.V.、Lacro, J. P.、Bailey, A.、Rockwell, E.、Harris, M. J.、Caligiuri, M. P.(1999)。Lower incidence of tardive dyskinesia with risperidone compared with haloperidol in older patients。J AM Geriatr Soc，47，716-719。 | | 7. | Morgenstem, H.、Glazer, W.M.(1993)。Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study。Arch Gen Psychiatry，50，723-733。 | | 8. | Browne, S.、Roe, M.、Lane, A.(1996)。Quality of life in schizophrenia: relationship to sociodemographic factors, symptomatology and tardive dyskinesia。Acta Psychiatr Scand，94，118-124。 | | 9. | Correll, C.U.、Leucht, S.、Kane, J.M.(2004)。Lower risk for tardive dyskinesia associated with second generation antipsychotics: a systematic review of 1-year studies。Am J Psychiatry，161，414-425。 | | 10. | Kane, J.M.、Eerdekens, M.、Lindenmayer, J.P.(2003)。Long-acting injectable resperidone: efficacy and safety of the first long-acting atypical antipsychotic。Am J Psychiatry，160，1125-1132。 | | 11. | Oosthuizen, P.P.、Emsley, R.A.、Maritz, J.S.、Turner, J.A.、Keyter, N.(2003)。Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol。J Clin Psychiatry，64，1075-1080。 | | 12. | Faurbye, A.、Rasch, P.J.、Peterson, P.B.、Brandborg, G.、Pakkenberg, H.(1964)。Neurological symptoms in phar-macotherapy of psychosis。Acta Psychiat Scand，40，10-27。 | | 13. | Levin, R.、Price, T. R. P.(1978)。The effect of electroconvulsive therapy on tardive dyskinesia。Am J Psychiatry，135，991-993。 | | 14. | Casey, D.E.(1999)。Tardive dyskinesia and atypical drugs。Schizophr Res，35，561-566。 | | 15. | Glazer, W.(2000)。Expected incidence of tardive dyski-nesia associated with atypical antipsychotics。J Clin Psychiatry，61，21-26。 | | 16. | Glazer, W.(2000)。Review of the incidence studies of tardive dyskinesia with antipsychotics。J Clin Psy，61，15-20。 | | 17. | Waddington, J.L.(1987)。Tardive dyskinesia in schizohrenia and other disorders: Association with aging, cognitive dysfunction, and structural brain pathology in relation to neuroleptic exposure。Hum Psychopharmacol，2，11-22。 | | 18. | Yassa, R.、Jeste, D.V.(1992)。Gender difference in tar dive dyskinesia: a critical review of the literature。Schizophr Bull，18，701-715。 | 研究報告| 1. | (1980)。Tardive dyskinesia。Washington, D.C.：American Psychiatric Association。 | 圖書| 1. | Dalery, Jean、d'Amato, Thierry(1999)。La Schizophrénie: recherches actuelles et perspectives。Masson。 | |